4Filing Date: Oct 2, 2026
Hims & Hers Health 4: CLO sells 3,461 shares (Oct 2, 2026)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001837817-26-000017
Total Value$101.0K
Trades1
Insiders1
Transaction Details
Boughton Soleil
Chief Legal Officer·Direct
Sell · Dispose
Class A Common Stock
Shares-3.46K
Price$29.17
Total Value$101.0K
Shares Owned After300.81K
Transaction DateSep 30, 2026
10b5-1
Footnotes ▸
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.
Post-Transaction Holdings
Boughton Soleil · Chief Legal Officer
| Security | Shares | Change |
|---|---|---|
| Class A Common Stock | 300.81K | -3.46K (-1.14%) |
auto_awesomeDeep Analysis
Deep Analysis
Hims & Hers Chief Legal Officer Soleil Boughton sold 3,461 Class A shares for $100,957 at $29.17 under a pre-set Rule 10b5-1 plan — a routine, small slice of a 300,809-share stake.
lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-30
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: Hims & Hers Health, Inc. (HIMS)
CIK: 0001773751
--- Reporting Owner ---
Name: Boughton Soleil
CIK: 0001837817
Role: Officer (Chief Legal Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Class A Common Stock
Date: 2026-09-30 | Code: S (Open market sale)
Shares: -3,461 | Price: $29.17
Total Value: $100,957.37
Shares Owned After: 300,809 | Ownership: D (Direct)
Footnotes:
[F1] The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.
--- Footnotes (Complete Index) ---
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026 by the Reporting Person.
--- Signature ---
/s/ /s/ Kimberly Mather, Attorney-in-Fact for Soleil Boughton (2026-10-02)